InVivoMAb Anti-SARS-CoV-2 RBD Antibody
- Cat. No.：RB9TVK565010
- Price：Negotiable
- Clicks：444
Product Detail
Product Parameters
| Product Description | S309 is a monoclonal antibody that targets the spike (S) glycoprotein of SARS-CoV-2. It potently neutralizes SARS-CoV-2 and SARS-CoV by binding a conserved glycan-containing epitope in the receptor-binding domain, without blocking receptor attachment. S309 has demonstrated strong neutralization alone and in antibody cocktails, offering potential for prophylaxis and post-exposure therapy. |
|---|---|
| Form | Liquid |
| Host Species | Human |
| Clonality | Monoclonal |
| Isotype | IgG1, kappa |
| Purity | >95% as determined by SDS-PAGE. |
| Purification | Protein A/G purified from cell culture supernatant. |
| Concentration | 1 mg/ml |
| Endotoxin Level | Please contact with the lab for this information. |
| Applications | ELISA, Neutralization |
| Species Reactivity | SARS-CoV-2(2019-nCoV), SARS-CoV |
| Target | Spike glycoprotein, S glycoprotein, E2, Peplomer protein, RBD, Spike protein S1, S, Receptor-Binding Domain |
| Storage Buffer | 0.01M PBS, pH 7.4. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| Accession Number | P0DTC2 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
Related Products: